ArticleThe Journal of clinical investigation2022

A translatable RNAi-driven gene therapy silences PMP22/Pmp22 genes and improves neuropathy in CMT1A mice.

Marina Stavrou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.